XML 14 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development $ 69,416 $ 63,006 $ 147,403 $ 123,812
General and administrative 27,488 13,061 55,361 26,983
Total operating expenses 96,904 76,067 202,764 150,795
Loss from operations (96,904) (76,067) (202,764) (150,795)
Other income:        
Other income, net 13,184 4,940 26,483 10,372
Total other income 13,184 4,940 26,483 10,372
Net loss $ (83,720) $ (71,127) $ (176,281) $ (140,423)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (2.87) $ (3.31) $ (6.08) $ (6.60)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (2.87) $ (3.31) $ (6.08) $ (6.60)
Weighted average common shares outstanding, basic (in shares) 29,131,375 21,474,827 29,008,351 21,266,490
Weighted average common shares outstanding, diluted (in shares) 29,131,375 21,474,827 29,008,351 21,266,490